Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection

The severity of bloodstream infections (BSI) depends on pathogen, source, and host factors. Secretory leukocyte protease inhibitor (SLPI) counteracts tissue damage, balances inflammation, and is increased in pneumonia and sepsis. We aimed to evaluate whether SLPI production differs depending on etio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Anna, Cajander, Sara, Magnuson, Anders, Sundén-Cullberg, Jonas, Strålin, Kristoffer, Hultgren, Olof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647850/
https://www.ncbi.nlm.nih.gov/pubmed/31089838
http://dx.doi.org/10.1007/s10096-019-03567-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647850/
https://www.ncbi.nlm.nih.gov/pubmed/31089838
http://dx.doi.org/10.1007/s10096-019-03567-2

Ejemplares similares